Smart Practice
SmartPractice Denmark ApS is a pharmaceutical niche company that develops and manufactures FDA-approved patch testing products for diagnosing allergic contact dermatitis, serving dermatologists and clinics in over 20 countries.
- Company typePrivate
- Founded1969
- HeadquartersHillerød, Denmark
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Smart Practice does
SmartPractice Denmark ApS is a pharmaceutical niche company specializing in contact allergy diagnostics, headquartered in Hillerød, Denmark, and operating as a subsidiary of the US-based SmartPractice group founded by Curt Hamann in 1969 (originally as Semantodontics). The Danish facility employs approximately 50 staff, including 12 laboratory technicians and 7 chemists working across pharmaceutical development, analytical development, microbiological quality control, and chemical quality control under GMP standards. The company serves dermatologists, allergists, and patch testing clinics worldwide, with products distributed through owned sales entities in the USA (Allerderm, Phoenix AZ), Germany (SmartPractice Europe GmbH), and Italy (SmartPractice Italy srl), plus an authorized distributor network covering more than 20 countries.
The company's core product is T.R.U.E. TEST, a ready-to-use, FDA-approved patch test panel containing up to 34-36 allergens and allergen mixes responsible for approximately 80% of allergic contact dermatitis (ACD) cases. Each panel uses proprietary dehydrated hydrophilic gel technology attached to a waterproof backing, where perspiration and transepidermal water loss rehydrate the gel to release allergens onto the skin. The product portfolio has been built through a series of acquisitions (Allerderm 2004, Mekos Laboratories Denmark 2006, Epitest/Finn Chambers 2008, Hayes Chamber 2012, EpiCutantest Hermal/TROLAB 2013) and complemented by internally developed adjuncts including the TruVol Precision Allergen Dispenser (2014), TruCase Allergen Attache (2016), and the Reveal & Conceal Cobalt Spot Test. Clinical evidence spans 40+ studies and 5,500+ patients, supporting claims of up to 80% ACD identification and a 50% reduction in disease duration when patch testing is incorporated into treatment.
Revenue is generated primarily through hardware/consumable sales of diagnostic patch test products to healthcare professionals and clinics. The Contact Dermatitis Institute — an online community offering paid learning modules, webinars, allergen reference libraries, and a physician locator service — functions as a community-led demand generation and professional services channel. Pricing is not publicly disclosed and is provided through direct sales representatives or distributors. Customer acquisition leverages dermatology conference participation (including ESCD and ACDS), a periodic newsletter, the annual Patch Test Workshop, and patient-facing educational content that drives referrals to clinics using SmartPractice products.
Smart Practice firmographics
Firmographics- Name
- Smart Practice
- Legal name
- SmartPractice Denmark ApS
- Website
- https://smartpractice.dk
- Company type
- Private
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- SmartPractice Denmark ApS is a pharmaceutical niche company that develops and manufactures FDA-approved patch testing products for diagnosing allergic contact dermatitis, serving dermatologists and clinics in over 20 countries.
- Ownership category
- akta.pro rank
Smart Practice industry classification
Industry- Product category
- Dermatology Diagnostics
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK)
- akta.pro secondary industries
- Contact Dermatitis & Patch Testing (HLAKACAK), Autoimmune & Allergy Diagnostics (HLAAALAK)
Keywords
Where Smart Practice is headquartered
LocationHeadquarters
- HQ city
- Hillerød
- HQ country
- Denmark
- HQ region
- Europe
Offices4 records
Markets served
Smart Practice business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Diagnostic Patch Testing Products: SmartPractice generates revenue primarily through the sale of its dermatological diagnostic products for contact allergy detection. These include T.R.U.E. TEST (ready-to-use patch test panels), allergEAZE (chambers and allergens), Finn Chambers, and related accessories and consumables to dermatologists, healthcare professionals, clinics, and medical practices worldwide through direct sales and distributor networks.
- Educational Resources and Training: Revenue is generated through the Contact Dermatitis Institute which provides paid learning modules, webinars, and educational resources for healthcare professionals and clinic staff training on patch testing and contact dermatitis diagnosis.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
Smart Practice product offering
Product offeringCore offering
SmartPractice Denmark ApS is a pharmaceutical niche company that develops, manufactures, and globally distributes dermatological diagnostic products for the detection of allergic contact dermatitis (ACD). Its core offering is the T.R.U.E. TEST ready-to-use patch test system — the only FDA-approved diagnostic patch test for ACD — supplemented by allergEAZE allergens and chambers, Finn Chambers delivery systems, and supporting accessories such as the TruVol Precision Allergen Dispenser and TruCase Allergen Attache.
Product overview
Smart Practice operates as a dermatology and allergy diagnostics company offering a portfolio of patch testing products for allergic contact dermatitis diagnosis. The core offering is the FDA-approved T.R.U.E. TEST system, a ready-to-use patch test containing standardized allergens. Supporting the core product are acquired brands including allergEAZE (allergens and chambers) and Finn Chambers (delivery systems), along with precision tools such as TruVol Dispenser and TruCase Attache. The company also provides the Contact Dermatitis Institute as an educational resource for healthcare professionals and patients.
Differentiator
Problem solved
Functional benefit
Brands
- T.R.U.E. TEST: FDA-approved ready-to-use patch test for diagnosis of allergic contact dermatitis, containing up to 36 allergens and allergen mixes
- allergEAZE
- Finn Chambers
- TruVol
- TruCase Allergen Attache
- Reveal & Conceal
- Contact Dermatitis Institute
Products and services
- T.R.U.E. TEST FDA-approved ready-to-use patch test for diagnosing allergic contact dermatitis (ACD); contains up to 36 allergens and allergen mixes on pre-prepared panels applied to the skin to identify causative agents of contact allergies. Sold to dermatologists and clinics globally.
- allergEAZE Brand of standardized patch test allergens in petrolatum and test chambers for custom patch testing configurations, used by dermatologists and allergy specialists for contact dermatitis diagnosis.
- Finn Chambers Aluminum patch test chambers used to deliver allergens during patch testing procedures, used by clinicians performing contact dermatitis diagnosis.
- TruVol Precision Allergen Dispenser Precision dispenser designed to deliver consistent and reliable volumes of petrolatum allergens during patch testing, ensuring standardized dosing in clinical workflows.
- TruCase Allergen Attache Allergen storage and organization case for patch testing clinics, launched in 2016 to support workflow in clinical environments.
- Reveal & Conceal Cobalt Spot Test Colorimetric spot test that detects cobalt release from metal objects (minimum 8.3 ppm detection) using disodium-1-nitroso-2-naphthol-3,6-disulfonate reagent; helps clinicians establish clinical relevance of cobalt exposure in patients.
- Contact Dermatitis Institute Online education and community platform providing learning modules (from Contact Dermatitis 101 to Setting Up a Patch Test Clinic), webinars, an allergen information library, and a physician locator service for healthcare professionals performing patch testing.
Quantifiable outcome
- Up to 80% of ACD cases can be identified using TRUE TEST allergen panel
- +3 more outcomes
Companies that use Smart Practice
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
Smart Practice technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Smart Practice partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered minor and core.
- Inmunotek Australia Pty LtdminorAuthorized distributor for SmartPractice products (T.R.U.E. TEST, allergEAZE) in Australia and New Zealand. Located at L13/99 Walker Street, North Sydney NSW 2060, Australia. Contact: +61 1300 706 908.
- MAAB (Shanghai) Medical Device LimitedminorAuthorized distributor for SmartPractice T.R.U.E. TEST products in China. Located at 5F, No.1438 Hong Qiao Road, GIFC Phase II, Shanghai 200336. Operates www.truetest.com.cn.
- GHN Pharma Nordic ABminorAuthorized distributor for SmartPractice products across Nordic markets including Denmark, Finland, Iceland, Norway, and Sweden. Located at Flöjelbergsgatan 12, SE-431 37 Mölndal, Sweden.
- STALLERGENES GREERminorAuthorized distributor for SmartPractice products in France (6 rue Alexis de Tocqueville, 92160 Antony) and Switzerland (Aagertstrasse 11, CH-8305 Dietlikon).
- Diagenics Ltd.minorAuthorized distributor for SmartPractice products in the UK and Ireland. Located at South House 1, Bond Avenue, Bletchley, Milton Keynes MK1 1SW, United Kingdom.
- Gamida Ltd.minorAuthorized distributor for SmartPractice products in Israel. Located at P.O.B. 7804, Petach-Tikva 49170, Israel.
- Bipharma BVminorAuthorized distributor for SmartPractice products in the Netherlands. Located at Kwikzilverstraat 21, Postbus 60017, NL-1320 AA Almere.
- Benemedo Sp.z o.o.minorAuthorized distributor for SmartPractice T.R.U.E. TEST products in Poland. Located at Floriańska 2, 03-707 Warszawa. Operates www.truetest.info.pl.
- Marti Tor Allergia SLminorAuthorized distributor for SmartPractice products in Spain. Located at Ramón Turró 91, Parc Empresarial de Cervelló, 08758 Cervelló Barcelona.
- Albio Allerji ÜrünleriminorAuthorized distributor for SmartPractice products in Turkey. Located at Mustafa Mazhar Bey Sk. 41/4, TR-34730 Selamicesme, Istanbul.
- MAP.FZE RAKFTZminorAuthorized distributor for SmartPractice products across Middle East and North Africa markets including UAE, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, Egypt, and Yemen. Located at Business Park BC1, RAKFTZ, United Arab Emirates.
- Sato Pharmaceuticals Co., Ltd.minorAuthorized distributor for SmartPractice T.R.U.E. TEST products in Japan. Located at 5-27, 1-chrome, Motoakasaka, Minato-ku, Tokyo 107.
- Contact Dermatitis InstitutecoreSmartPractice sponsors and operates the Contact Dermatitis Institute, an online community providing ongoing research, educational resources, and interactive peer-to-peer community for the patch testing community and patients. The platform offers learning modules, webinars, allergen information libraries, and a physician locator service.
Scale indicators7 records
Recent moves7 records
Expansion highlights5 records
Smart Practice competitors and assessment
Company assessmentEmerging players
- Bühlmann Laboratories: Swiss specialty diagnostics company with calprotectin and other immunology assays. Comparable as a niche specialty diagnostics manufacturer serving clinical laboratories and dermatology/gastroenterology channels with reagent-based test systems.
- HOB Biotech: China-based allergy diagnostics company expanding in vitro allergy testing in Asia. Comparable as an emerging Asian allergy diagnostics player competing for regional share and clinical adoption in markets where SmartPractice also distributes.
Broad incumbents
- Thermo Fisher Scientific (Phadia): Through its Phadia allergy diagnostics business, Thermo Fisher is the dominant provider of in vitro IgE allergy testing (ImmunoCAP). Comparable as a large incumbent shaping clinical practice in allergy diagnostics, even though its modality (blood-based IgE) differs from SmartPractice's in vivo patch testing.
- ALK-Abelló: Danish global leader in allergy diagnostics and immunotherapy. While focused on respiratory/IgE allergies rather than contact dermatitis, ALK is highly comparable as a Danish allergy specialty company with broad global reach, R&D infrastructure, and overlapping clinician customer base.
- Allergy Therapeutics: UK-listed specialty allergy company focused on immunotherapy vaccines and diagnostics. Comparable as a publicly-traded allergy platform competing for clinician mindshare and R&D investment, though its modality and product mix differ from SmartPractice.
- HAL Allergy: Dutch allergy diagnostics and immunotherapy company with European-wide distribution. Comparable as an adjacent allergy specialist selling to dermatologists and allergists, providing a benchmark for specialty allergy commercial scale.
- Stallergenes Greer: Global allergy immunotherapy and diagnostics company that is also a SmartPractice authorized distributor for France and Switzerland. Comparable as a broader allergy platform with distribution scale and overlapping allergy clinician relationships, though centered on respiratory rather than contact allergy.
Direct peers
- Dr. Fooke Laboratorien: German manufacturer of patch test allergens and reference substances serving European dermatology clinics. Directly comparable as a specialist patch testing reagent supplier competing for the same clinical customers in EMEA.
- Chemotechnique Diagnostics: Sweden-based manufacturer of patch test allergens and the leading direct competitor to SmartPractice's allergEAZE franchise. Both companies sell standardized allergen series and patch test chambers to dermatologists globally, making them the closest 1:1 comparables in patch test diagnostics.
- Lincoln Diagnostics: US-based manufacturer of skin testing devices and antigens for allergy diagnosis. Comparable as a specialist supplier of in vivo skin testing tools serving the same dermatology/allergy clinician base as SmartPractice, particularly in North America.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Smart Practice compliance and trust
Trust signalCompliance2 records
Smart Practice financial estimates
Financial estimateRevenue estimate
Valuation estimate
Smart Practice leadership team
Management profileNumber of profiles
Profiles8 records
Smart Practice subsidiaries and ownership
Company hierarchySubsidiaries2 records
Smart Practice funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Smart Practice M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Smart Practice
What does Smart Practice do?
SmartPractice Denmark ApS is a pharmaceutical niche company that develops, manufactures, and globally distributes dermatological diagnostic products for the detection of allergic contact dermatitis (ACD). Its core offering is the T.R.U.E. TEST ready-to-use patch test system — the only FDA-approved diagnostic patch test for ACD — supplemented by allergEAZE allergens and chambers, Finn Chambers delivery systems, and supporting accessories such as the TruVol Precision Allergen Dispenser and TruCase Allergen Attache.
Is Smart Practice a public or private company?
Smart Practice is a private company. It is classified as corporate owned and is currently operating.
When was Smart Practice founded?
Smart Practice was founded in 1969. It employs 11 to 50 people.
Where is Smart Practice based?
Smart Practice is headquartered in Hillerød, Denmark, in the Europe region.
How does Smart Practice make money?
Two revenue lines are on record. Diagnostic Patch Testing Products are the primary driver. The others are educational Resources and Training.
Who are Smart Practice's main competitors?
Emerging players on record are Bühlmann Laboratories and HOB Biotech. Broad incumbents are Thermo Fisher Scientific (Phadia), ALK-Abelló, Allergy Therapeutics, HAL Allergy and Stallergenes Greer. Direct peers are Dr. Fooke Laboratorien, Chemotechnique Diagnostics and Lincoln Diagnostics.
Does Smart Practice have an API?
No public API is recorded for Smart Practice.
What industry is Smart Practice in?
Smart Practice's product category is Dermatology Diagnostics. Its primary akta.pro industry code is HLAHAAAK, Autoimmune, Allergy & Specialized Immunology Diagnostics, with a secondary code of HLAKACAK, Contact Dermatitis & Patch Testing. Its NAICS code is 339113 and its SIC code is 2835.